SEP 19, 2015 5:55 PM PDT

Two Genes Could Help with Treatment of Schizophrenia

WRITTEN BY: Ilene Schneider
The abnormal behavior of two genes (BDNF and DTNBP1) is related to the underlying cause of schizophrenia, providing a new target for schizophrenia treatment, according to research led by scientists from Duke-NUS Graduate Medical School Singapore (Duke-NUS). The study was published online in the journal Biological Psychiatry and reported in Drug Discovery & Development
Abnormal behavior of two genes causes schizophrenia. 
Schizophrenia, a devastating mental disorder, affects nearly 1 percent of the total human population. The primary cause of the disorder involves impaired brain development that eventually leads to imbalanced signals in the brain. This imbalance may cause hallucinations and paranoia in people with schizophrenia.
 
As senior author Assistant Professor Shawn Je, from the Neuroscience and Behavioral Disorders Programme at Duke-NUS, explained, "We wanted to understand the mechanism by which the brain circuit operates. In particular, we wanted to understand the ability of a specific type of cell in the brain, termed interneurons, to modulate brain network activity to maintain a balance in brain signalling."
 
Dr. Je and his team analyzed signaling activity in neuronal cultures that either did not have the DTNBP1 gene or had lowered levels of the gene. They found that reduced DTNBP1 levels and genetic disruptions of DTNBP1 in mice resulted in schizophrenia-like behaviors. When using multiple model systems, they discovered that the low levels of DTNBP1 caused dysfunctional interneurons and over-activated neuronal network activity. Lowering levels of DTNBP1 also reduced the levels of the secreted protein molecule, BDNF.
 
The researchers showed that BDNF was one of the most important factors that regulate the development of a normal brain circuit. BDNF plays an important role in the interneurons’ ability to connect to the brain. Interneurons receive BDNF via a transport system controlled by DTNBP1. Think of the process as the delivery of a parcel: DTNBP1 acts as the driver of the delivery van. Without the driver, the parcel BDNF cannot be delivered to the required destination. If BDNF is lacking, there is abnormal circuit development and brain network activity observed in schizophrenia patients. Dr. Je and his team also found that when BDNF levels were restored, brain development and activity were rescued and returned to more normal levels, despite the absence of DTNBP1.
 
DTNBP1 and BDNF have been singled out as risk genes for schizophrenia in studies before, but this is the first study to demonstrate that the two work together. Highlighting the importance of the abnormal delivery of BDNF has offered much insight into how the brain network develops. The study also offers possibilities for new treatments for schizophrenia based on enhancing BDNF levels.
 
Dr. Je plans to do a follow-up study to determine whether these findings are viable in an animal model. If he and his colleagues are successful, it could mean that changing the imbalance in the brain circuits of schizophrenia patients could bring us closer to developing a treatment.
 
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
SEP 14, 2020
Clinical & Molecular DX
Peek into the Inner Workings of the Spinal Cord
SEP 14, 2020
Peek into the Inner Workings of the Spinal Cord
Scientists have established a state-of-the-art method for observing and analyzing the complex flurry of neurological act ...
SEP 16, 2020
Neuroscience
Blood Lipid Levels Predict Depression and Anxiety
SEP 16, 2020
Blood Lipid Levels Predict Depression and Anxiety
While people often experience anxiety and depression together, psychiatrists classify them as different disorders. And n ...
NOV 01, 2020
Microbiology
SARS-CoV-2 Disrupts the Blood Brain Barrier
NOV 01, 2020
SARS-CoV-2 Disrupts the Blood Brain Barrier
SARS-CoV-2, which causes COVID-19 has to get into cells to cause infection. It does so with a spike protein on its surfa ...
NOV 06, 2020
Clinical & Molecular DX
Your Earwax Says You're Depressed
NOV 06, 2020
Your Earwax Says You're Depressed
Cortisol, commonly known as the “stress hormone”, is the body’s built-in alarm system that sends siren ...
NOV 07, 2020
Cannabis Sciences
Does Cannabis Make Bipolar Disorder Better or Worse?
NOV 07, 2020
Does Cannabis Make Bipolar Disorder Better or Worse?
While anecdotal evidence and some case studies suggest cannabis may benefit those with bipolar disorder, studies have re ...
NOV 09, 2020
Drug Discovery & Development
New Immunotherapy Shows Promise for MS
NOV 09, 2020
New Immunotherapy Shows Promise for MS
Researchers from Thomas Jefferson University in Philadelphia are studying an immunotherapy that has shown early pro ...
Loading Comments...